Thursday
09.19.2019
9:56 PM
Login form
Search
Calendar
Entries archive

My site

Main » 2013 » April » 14
RESEARCH TRIANGLE PARK, N.C. - Friday, April 12th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Quintiles today announced that it has been chosen as a preferred provider by Bristol-Myers Squibb Company (NYSE:BMY) to provide global support for Bristol-Myers Squibb’s central lab work, biomarker testing and assay development for the next five years.

"This agreement deepens the commitment our companies share to providing patients access to effective, safe and affordable treatments,” said Thomas Wollman, Senior Vice President of Quintiles Global Laboratories. "We look forward to working with Bristol-Myers Squibb to bring personalized medicine into mainstream drug development.”

About Quintiles

Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50, best-selling drug ... Read more »
Views: 93 | Added by: uaeonlinenews | Date: 04.14.2013